Your weekly roundup of the latest news from Drug Topics®.
According to the agency, this new authority may improve access to patients at high risk for severe COVID-19.
New research indicates dulaglutide is effective in improving glycemic control in pediatric patients with diabetes.
The effect of acne is more than skin deep.
Hypertension adversely impacts the multiple sclerosis (MS) disease course and is more common among Black Americans.
Purchase follows FDA recommendation to include Omicron component in boosters.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.